The U.S. National Institutes of Health (NIH) has recently agreed to reevaluate numerous medical science grant applications that were put on hold due to diversity-related restrictions implemented by the Trump administration. This decision comes after ongoing legal battles over science funding, with the NIH committing to assess each grant based on scientific merit and disregarding any antidiversity orders that were previously in place.
The halted research projects covered by the lawsuit, which was filed against the NIH by various science organizations and individual scientists, encompass a wide range of topics including Alzheimer’s research, HIV, minority health, and sexual violence. Researchers like Nikki Maphis from the University of New Mexico, who focuses on brain aging, Alzheimer’s, and alcohol use effects, expressed optimism about having their funding proposals fairly evaluated moving forward.
In a previous ruling, a federal judge deemed hundreds of terminated NIH grants as “void” and “illegal” for violating discrimination laws. However, the status of stalled grant applications was left pending a separate decision. The Trump administration’s directives issued in February and May had effectively restricted funding for research on diversity objectives, gender identity, and COVID-related studies. While the Supreme Court declined to intervene in the case, it acknowledged that the NIH’s directives were unreasonable and unlawful.
The recent agreement between the NIH and the plaintiffs ensures that the stalled grant applications will be reviewed without applying the previously challenged directives. Although the NIH has not committed to funding the studies, it will undertake a thorough evaluation process. The agency reiterated its commitment to supporting evidence-based research that benefits all Americans.
While the agreement does not guarantee funding for the studies, it represents a significant step forward for impacted researchers and science advocates. Colette Delawalla of the science advocacy group Stand Up for Science emphasized the importance of this progress, particularly for early-career scientists who have been disproportionately affected by the government’s intervention in the grant review process.
As the legal proceedings continue, the NIH’s decision to reopen stalled grant applications for review signifies a positive development in the ongoing dispute over science funding. Science advocates are hopeful that this agreement will pave the way for fair evaluations and potential funding for vital research projects in the future.
